Evolution of A(H1N1) pdm09 influenza virus masking by glycosylation

被引:8
|
作者
Ge, Pan [1 ]
Ross, Ted M. [1 ,2 ]
机构
[1] Univ Georgia, Ctr Vaccines & Immunol, Athens, GA 30602 USA
[2] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA
关键词
Glycosylation; HA; influenza; mutation; N-LINKED GLYCOSYLATION; HEMAGGLUTININ MEMBRANE GLYCOPROTEIN; RECEPTOR-BINDING SPECIFICITY; AMINO-ACID SUBSTITUTIONS; A VIRUS; GENETIC-CHARACTERIZATION; H1N1; RECOGNITION; ACTIVATION; VIRULENCE;
D O I
10.1080/14760584.2021.1908135
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: As the pathogen that caused the first influenza virus pandemic in this century, the swine-origin A(H1N1) pdm09 influenza virus has caused continuous harm to human public health. The evolution of hemagglutinin protein glycosylation sites, including the increase in number and positional changes, is an important way for influenza viruses to escape host immune pressure. Based on the traditional influenza virus molecular monitoring, special attention should be paid to the influence of glycosylation evolution on the biological characteristics of virus antigenicity, transmission and pathogenicity. The epidemiological significance of glycosylation mutants should be analyzed as a predictive tool for early warning of new outbreaks and pandemics, as well as the design of vaccines and drug targets. Areas covered: We review on the evolutionary characteristics of glycosylation on the HA protein of the A(H1N1)pdm09 influenza virus in the last ten years. Expert opinion: We discuss the crucial impact of evolutionary glycosylation on the biological characteristics of the virus and the host immune responses, summarize studies revealing different roles of glycosylation play during host adaptation. Although these studies show the significance of glycosylation evolution in host-virus interaction, much remains to be discovered about the mechanism.
引用
收藏
页码:519 / 526
页数:8
相关论文
共 50 条
  • [21] Critically Ill Patients With Influenza A(H1N1)pdm09 Virus Infection in 2014
    Napolitano, Lena M.
    Angus, Derek C.
    Uyeki, Timothy M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (13): : 1289 - 1290
  • [22] Activity of Thermopsis schischkinii Alkaloids Against Influenza A(H1N1)pdm09 Virus
    Tsypysheva, I. P.
    Galkin, E. G.
    Baikova, I. P.
    Fedorov, N. I.
    Petrova, P. R.
    Orshanskaya, Ya. R.
    Fedorova, V. A.
    Zarubaev, V. V.
    CHEMISTRY OF NATURAL COMPOUNDS, 2015, 51 (05) : 1003 - 1005
  • [23] Oseltamivir-resistant influenza A(H1N1)pdm09 virus in southern Brazil
    Marx, Camila
    Gregianini, Tatiana Schaeffer
    Moreira Lehmann, Fernanda Kieling
    Lunge, Vagner Ricardo
    de Carli, Silvia
    Dambros, Bibiana Paula
    Tumioto, Gabriela Luchiari
    Seadi, Claudete
    Kazantzi Fonseca, Andre Salvador
    Ikuta, Nilo
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2013, 108 (03): : 392 - 394
  • [25] Seroprevalence of Influenza A(H1N1) pdm09 Virus Antibody, England, 2010 and 2011
    Hoschler, Katja
    Thompson, Catherine
    Andrews, Nick
    Galiano, Monica
    Pebody, Richard
    Ellis, Joanna
    Stanford, Elaine
    Baguelin, Marc
    Miller, Elizabeth
    Zambon, Maria
    EMERGING INFECTIOUS DISEASES, 2012, 18 (11) : 1894 - 1897
  • [26] Genetic characterization of influenza A(H1N1)pdm09 virus in 2023 in Huzhou, China
    Xu, Deshun
    Chen, Liping
    Ji, Lei
    Yan, Wei
    JOURNAL OF CLINICAL VIROLOGY PLUS, 2024, 4 (02):
  • [27] Activity of Thermopsis schischkinii Alkaloids Against Influenza A(H1N1)pdm09 Virus
    I. P. Tsypysheva
    E. G. Galkin
    I. P. Baikova
    N. I. Fedorov
    P. R. Petrova
    Ya. R. Orshanskaya
    V. A. Fedorova
    V. V. Zarubaev
    Chemistry of Natural Compounds, 2015, 51 : 1003 - 1005
  • [28] Development of PREDAC-H1pdm to model the antigenic evolution of influenza A/(H1N1) pdm09 viruses
    Liu, Mi
    Liu, Jingze
    Song, Wenjun
    Peng, Yousong
    Ding, Xiao
    Deng, Lizong
    Jiang, Taijiao
    VIROLOGICA SINICA, 2023, 38 (04) : 541 - 548
  • [29] Fatal Influenza A(H1N1)pdm09 Encephalopathy in Immunocompetent Man
    Simon, Marie
    Hernu, Romain
    Cour, Martin
    Casalegno, Jean-Sebastien
    Lina, Bruno
    Argaud, Laurent
    EMERGING INFECTIOUS DISEASES, 2013, 19 (06) : 1005 - 1007
  • [30] Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe
    Mereckiene, J.
    Cotter, S.
    Weber, J. T.
    Nicoll, A.
    D'Ancona, F.
    Lopalco, P. L.
    Johansen, K.
    Wasley, A. M.
    Jorgensen, P.
    Levy-Bruhl, D.
    Giambi, C.
    Stefanoff, P.
    Dematte, L.
    O'Flanagan, D.
    EUROSURVEILLANCE, 2012, 17 (04) : 18 - 27